DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(287.31%) (323.64%) 6,746.19% 546.62%

+8 more TTM periods

Piotroski F-Score
6 6 6 5
ROA
4.81% 4.51% 4.30% 4.40%
ROIC
13.90% 13.75% 13.71% 13.96%
Return on Tangible Assets
20.75% 19.78% 20.03% 19.55%
Average Days of Receivables
81.21 79.48 79.16 81.83
Free Cash Flow per Share
25.10 22.55 18.12 18.49
Free Cash Flow
1,625.97 1,519.92 1,344.81 1,332.57
Capital Expenditures
(567.19) (507.40) (541.69) (560.83)
Other line items
Cash ROIC
14.64% 13.84% 12.36% 12.31%
Accounts Receivable Turnover
4.58 4.79 4.95 4.74
Accounts Payable Turnover
14.47 14.52 14.87 15.84
Inventory Turnover
63.64 63.98 62.63 67.58
Average Days of Payables
27.57 27.00 27.49 26.41
Days of Inventory on Hand
5.84 5.53 6.34 5.60
Tax Rate
(0.21) (0.22) (0.22) (0.20)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.36% 12.44% 12.27% 12.13%
Share Based Compensation of Revenue
0.94% 1.00% 1.03% 0.97%
Operating CF/Net income
2.59 2.59 2.53 2.45
Depreciation/Fixed assets
0.26 0.26 0.25 0.25
Capex/Depreciation
(0.80) (0.71) (0.76) (0.80)
Revenue per Share
216.26 205.30 183.80 184.78
Operating CF per Share
33.85 30.08 25.42 26.27
Capex per Share
(8.76) (7.53) (7.30) (7.78)
Capex to Sales
0.04 0.04 0.04 0.04

Fold the line items

Columns are period end dates